Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences. www.marketwatch.com #Abbott…
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences. www.marketwatch.com #Abbott…
Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp. in a deal with a total equity value of about…